ストックスクリーナーアプリを入手
3.44
0.58%
-0.02
アフターアワーズ：
3.48
0.04
+1.16%
前日終値:
$3.46
開ける：
$3.515
24時間の取引高:
1.16M
Relative Volume:
0.91
時価総額：
$220.26M
収益：
-
当期純損益:
$-36.95M
株価収益率:
-4.0952
EPS:
-0.84
ネットキャッシュフロー:
$-33.46M
1週間 パフォーマンス:
-11.34%
1か月 パフォーマンス:
+19.44%
6か月 パフォーマンス:
-10.42%
1年 パフォーマンス:
-58.65%
1日の値動き範囲:
$3.40
$3.5499
1週間の範囲:
$3.27
$3.91
52週間の値動き範囲:
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
名前
Larimar Therapeutics Inc
セクター
電話
844-511-9056
住所
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
LRMR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.44 | 221.54M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-29 | 開始されました | Truist | Buy |
| 2024-10-16 | 開始されました | Oppenheimer | Outperform |
| 2024-10-03 | 開始されました | Wedbush | Outperform |
| 2024-10-02 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-04 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-03 | 開始されました | Leerink Partners | Outperform |
| 2023-11-17 | アップグレード | Citigroup | Neutral → Buy |
| 2022-10-19 | 開始されました | Guggenheim | Buy |
| 2022-02-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-02-01 | 開始されました | William Blair | Outperform |
すべてを表示
Larimar Therapeutics Inc (LRMR) 最新ニュース
What are the technical indicators suggesting about Larimar Therapeutics Inc.Unlock powerful market insights for success - jammulinksnews.com
What are Larimar Therapeutics Inc. company’s key revenue driversDiscover breakthrough stocks before the crowd - jammulinksnews.com
How does Larimar Therapeutics Inc. compare to its industry peersBreakout Stocks Tracker With High Returns - jammulinksnews.com
Larimar Therapeutics raises $69 million in public offering - Investing.com
Larimar Therapeutics raises $69 million in public offering By Investing.com - Investing.com India
Why Larimar Therapeutics Inc. is moving todayAutomated AI Forecast with Trading Alerts - Newser
Relative strength of Larimar Therapeutics Inc. in sector analysisSmart Trade Mapping with Entry Details - Newser
Analyzing recovery setups for Larimar Therapeutics Inc. investorsOversold Reversal Picks with Buy Zone - Newser
Short interest data insights for Larimar Therapeutics Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
Larimar Therapeutics Announces Closing of Underwritten - GlobeNewswire
Larimar Therapeutics Announces Closing of Underwritten Public Of - GuruFocus
Larimar Therapeutics Closes $69 Million Public Offering of Common Stock to Support Development of Pipeline Candidates - Quiver Quantitative
Rare Disease Biotech Larimar Secures $69M Windfall as Investors Rush to Oversubscribed Stock Offering - Stock Titan
Larimar Therapeutics Announces $64.4 Million Stock Offering - TipRanks
Using R and stats models for Larimar Therapeutics Inc. forecastingShort-Term AI-Based Stock Price Forecast - Newser
What recovery options are there for Larimar Therapeutics Inc.Free High Win Rate Trading Opportunities - Newser
What indicators show strength in Larimar Therapeutics Inc.Predictive System for Long-Term Stock Forecast - Newser
Is it time to cut losses on Larimar Therapeutics Inc.Conservative Entry for High Return Setup Backed - metal.it
Is Larimar Therapeutics Inc. stock overhyped or has real potentialFree Trade Setups With AI Powered Filters - Newser
Will Larimar Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Larimar Therapeutics stock falls after $60 million public offering By Investing.com - Investing.com Canada
Multi asset correlation models including Larimar Therapeutics Inc.Free Breakout Momentum Picks With Protection - Newser
Larimar Therapeutics Inc. Stock Support and Resistance Levels You Should KnowIntelligent Trade Forecast With AI Analytics - Newser
LRMR Stock Priced at Lower End of Predetermined Range - GuruFocus
What makes Larimar Therapeutics Inc. stock price move sharplyTechnical Trade Plan with Entry Checklist - Newser
Striking the Balance: Larimar Therapeutics' $60M Raise and the Road to Nomlabofusp Approval - AInvest
Larimar Therapeutics Announces Pricing of Underwritten Public Offering | LRMR Stock News - GuruFocus
Larimar Therapeutics prices public offering at $3.20 per share By Investing.com - Investing.com South Africa
Larimar Therapeutics prices public offering at $3.20 per share - Investing.com
Larimar Therapeutics, Inc. Announces Pricing of $60 Million Public Offering of Common Stock - Quiver Quantitative
$60M Public Offering: How Larimar Therapeutics Plans to Advance Rare Disease Treatments - Stock Titan
Larimar Therapeutics Announces Pricing of Underwritten Public Offering - Yahoo Finance
Larimar Therapeutics Announces Pricing of Underwritten Public Offering - GlobeNewswire Inc.
Larimar Therapeutics Inc. Crosses 200 Day MA — Signal or NoiseLow Risk Equity Screener With Results Shared - metal.it
Larimar Therapeutics (LRMR) Launches Public Offering to Boost Development Efforts - GuruFocus
Form 424B5 Larimar Therapeutics, - StreetInsider
Larimar Therapeutics launches public offering of common stock By Investing.com - Investing.com Nigeria
Larimar Therapeutics Announces Proposed Underwritten Public Offe - GuruFocus
Larimar Therapeutics launches public offering of common stock - Investing.com Australia
Larimar Therapeutics Announces Proposed Underwritten Public Offering - GlobeNewswire
Rare Disease Biotech Larimar Therapeutics Unveils Strategic Public Offering for Breakthrough Drug Development - Stock Titan
Larimar Therapeutics Inc. Consolidation Zone May Signal AccumulationSecure Return Focused Investment Plan Released - metal.it
Larimar Therapeutics Inc. Trading Near Value Zone — Recovery AheadCommunity Shared Smart Money Signals Show Movement - metal.it
How to escape a deep drawdown in Larimar Therapeutics Inc.Free Smart Trade Plans With Risk Protection - Newser
Larimar Therapeutics Bets Big On Rare Disease Breakthrough - Finimize
What is Larimar Therapeutics Inc. company’s growth strategyProven strategies for superior portfolio growth - jammulinksnews.com
Why is Larimar Therapeutics Inc. stock attracting strong analyst attentionBuild wealth faster with disciplined trading - jammulinksnews.com
Should I hold or sell Larimar Therapeutics Inc. stock in 2025Consistently outstanding ROI - jammulinksnews.com
Larimar Therapeutics Inc (LRMR) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):